Marketing-authorisation holder · United States
Somerset Theraps LLC
9 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
9 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACETYLCYSTEINE10% | 20% · Solution | Acetylcysteine | United States | Marketed | 1992 |
| ATROPINE SULFATE0.25mg/5ml (0.05mg/ml) | 0.4mg/ml (0.4mg/ml) | 0.5mg/5ml (0.1mg/ml) | 1mg/10ml (0.1mg/ml) | 1mg/ml (1mg/ml) · Solution | Atropine | United States | Marketed | 2001 |
| ATROPINE SULFATE8mg/20ml (0.4mg/ml) · Solution | Atropine | United States | Marketed | 2018 |
| PILOCARPINE HYDROCHLORIDE1.25% | 1% | 2% | 4% · Solution/drops | Pilocarpine | United States | Marketed | 2017 |
| RILPIVIRINE HYDROCHLORIDE25mg base · Tablet | Rilpivirine | United States | Marketed | 2026 |
| ROPIVACAINE HYDROCHLORIDE100mg/10ml (10mg/ml) | 100mg/20ml (5mg/ml) | 150mg/20ml (7.5mg/ml) | 150mg/30ml (5mg/ml) | 1gm/200ml (5mg/ml) | 200mg/100ml (2mg/ml) | 200mg/20ml (10mg/ml) | 20mg/10ml (2mg/ml) | 400mg/200ml (2mg/ml) | 40mg/20ml (2mg/ml) | 500mg/100ml (5mg/ml) · Solution | Ropivacaine | United States | Marketed | 2014 |
| TOBRAMYCIN0.3% · Solution/drops | Tobramycin | United States | Marketed | 1993 |
| ELTROMBOPAG OLAMINE25mg · Tablet | Eltrombopag | United States | tentative | 2026 |
| RILPIVIRINE2.5mg · Tablet | Rilpivirine | United States | tentative | 2026 |